Mutational signature dynamics indicate SARS-CoV-2's evolutionary capacity is driven by host antiviral molecules. (2024)
Attributed to:
Integrative viral genomics and bioinformatics platform
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1371/journal.pcbi.1011795
PubMed Identifier: 38271457
Publication URI: http://europepmc.org/abstract/MED/38271457
Type: Journal Article/Review
Volume: 20
Parent Publication: PLoS computational biology
Issue: 1
ISSN: 1553-734X